CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
- 4 Open-market buy Chief Commercial Officer bought 4,000 shares at $24.40 ($97,600)
- 4 Open-market sale Director sold 17,557 shares at $31.33 ($550,061)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 100 shares (code L)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Strategy & Innovation sold 6,067 shares at $18.81 ($114,120)
- 4 Open-market sale Director sold 11,064 shares at an average $18.68 ($206,701)
- 4 Shares withheld for taxes CEO gave up 5,076 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 8,229 shares (option exercise)
Page 7 of 19 · 370 filings